Congress Is Back From Break
Here’s what we’re looking for now that Congress is back from summer recess and we enter the final four…
There’s No Escaping Arcus Biosciences, Inc.’s (NYSE:RCUS) Muted Revenues Despite A 28% Share Price Rise
Arcus Biosciences, Inc. (NYSE:RCUS) shareholders would be excited to see that the share price has had a great month,…
Crypto ETFs hemorrhage $607M in single day of record outflows
The bullish tide that carried Bitcoin and Ethereum to hit new records in August has turned sharply. Even crypto-linked…
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Looks Just Right With A 32% Price Jump
Despite an already strong run, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares have been powering on, with a gain of 32%…
Here’s how a weak jobs report could spell gains for crypto
The August jobs report is in, and depending on your perspective, it’s either worrying or the next big catalyst…
Stock Analysis | DaVita Outlook
DaVita Outlook – Mixed Signals Amid Market Volatility Market Snapshot: DaVita’s stock remains in a weak technical position, with…
An Under-$1 Opportunity: Why Crypto Gurus Favor XYZVerse Over Cardano (ADA) for Novice Investors
XYZVerse attracts significant attention from market experts. Unlike Cardano (ADA), XYZVerse costs under $1 and is being recommended as…
Stock Market Drops: Risks of Buying the Dip
Sitthiphong / iStock.com Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information….
Further Upside For Empresas Lipigas S.A. (SNSE:LIPIGAS) Shares Could Introduce Price Risks After 29% Bounce
Despite an already strong run, Empresas Lipigas S.A. (SNSE:LIPIGAS) shares have been powering on, with a gain of 29%…
Best Crypto to Buy Despite South Korea Skepticism — XRP, ADA and MAGACOIN FINANCE Stay on Watchlists
Disclaimer: This is a Press Release provided by a third party who is responsible for the content. Please conduct…
recent post
-
Oct 12 2025 -
-
Oct 12 2025
-
Oct 12 2025
-
Oct 12 2025
